Herbal compounds in the treatment of pulmonary silicosis

Physiol Res. 2021 Dec 31;70(S3):S275-S287. doi: 10.33549/physiolres.934817.

Abstract

Herbal compounds including those already well-established in traditional Chinese medicine have been increasingly tested in the treatment of various diseases. Recent studies have shown that herbal compounds can be of benefit also for pulmonary silicosis as they can diminish changes associated with silica-induced inflammation, fibrosis, and oxidative stress. Due to a lack of effective therapeutic strategies, development of novel approaches which may be introduced particularly in the early stage of the disease, is urgently needed. This review summarizes positive effects of several alternative plant-based drugs in the models of experimental silicosis with a potential for subsequent clinical investigation and use in future.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use*
  • Antioxidants / therapeutic use*
  • Humans
  • Inflammation Mediators / metabolism
  • Lung / drug effects*
  • Lung / metabolism
  • Lung / pathology
  • Oxidative Stress / drug effects
  • Plant Preparations / adverse effects
  • Plant Preparations / therapeutic use*
  • Pulmonary Fibrosis / drug therapy*
  • Pulmonary Fibrosis / metabolism
  • Pulmonary Fibrosis / pathology
  • Reactive Oxygen Species / metabolism
  • Silicosis / drug therapy*
  • Silicosis / metabolism
  • Silicosis / pathology

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Inflammation Mediators
  • Plant Preparations
  • Reactive Oxygen Species